Iberogast® Balance (Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae Piperitae Folium, Melissae)

The product combines extracts of bitter candytuft, chamomile, peppermint and lemon balm. These botanicals act together to relax smooth muscle, modulate inflammatory pathways, enhance nitric‑oxide release and normalize gut motility, thereby alleviating functional gastrointestinal symptoms.

The prescribed dose of Iberogast® Balance is determined by the treating healthcare professional based on the individual’s condition, age and response. Patients should follow the prescriber’s instructions and the product label without deviating from the recommended regimen.

Safety data for Iberogast® Balance in pregnancy and lactation are limited. It should only be used if clearly needed and after a risk‑benefit assessment by a qualified clinician. Breastfeeding mothers should consult their healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑ingredient antispasmodics or acid‑suppressing agents, Iberogast® Balance offers a multi‑targeted botanical approach that addresses motility, inflammation and visceral sensitivity simultaneously. This broader mechanism may provide symptom relief for patients who do not respond adequately to conventional monotherapy.

Iberogast® Balance should be stored at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and retain it in the original packaging until use.

The product is taken orally, usually as a measured dose of the liquid preparation. It can be swallowed directly or mixed with a small amount of water or juice, following the dosage instructions provided by the prescriber.

Serious adverse events, although rare, include anaphylactic reactions, severe hypersensitivity with angioedema, and significant hepatic enzyme elevations. Patients should seek immediate medical attention if they experience difficulty breathing, swelling of the face or throat, or unexplained severe abdominal pain.

Individuals with a known allergy to any of its plant constituents should avoid Iberogast® Balance. It is also not recommended for children unless specifically prescribed, and caution is advised for patients on anticoagulants, antiplatelet therapy or those taking potent CYP3A4 inhibitors.